Material Event Form 8 K

Voluntary Petitions for Bankruptcy

On November 15, 2024, Seelos Therapeutics, Inc. (the "Company") filed a voluntary petition for relief (the "Bankruptcy Petition") under chapter 11 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court"). The Debtor will continue to operate its business as a "debtor-in-possession" under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court.